Kwok Cheni 4
4 · PONIARD PHARMACEUTICALS, INC. · Filed Jun 18, 2007
Insider Transaction Report
Form 4
Kwok Cheni
VP, Bus. Devlpt.
Transactions
- Award
Stock Option
2007-06-14+62,500→ 62,500 totalExercise: $3.66Exp: 2016-09-13→ Poniard Common Stock (62,500 underlying) - Award
Stock Option
2007-06-14+20,000→ 20,000 totalExercise: $5.98Exp: 2017-02-07→ Poniard Common Stock (20,000 underlying) - Award
Stock Option
2007-06-14+21,500→ 21,500 totalExercise: $8.14Exp: 2017-05-31→ Poniard Common Stock (21,500 underlying)
Footnotes (6)
- [F1]This stock option was approved on September 13, 2006 by the Equity Awards Subcommittee of the Compensation Committee of the Board of Directors, subject to shareholder approval of the amendment and restatement of the issuer's 2004 Incentive Compensation Plan, which the shareholders approved on June 14, 2007. The exercise price is equal to the closing market price of issuer's common stock on September 13, 2006, as adjusted for the one-for-six reverse stock split effected on September 22, 2006.
- [F2]This stock option vests (A) as to 50% of the total amount, in equal monthly amounts over four years from 9/13/06, subject to the reporting person being employed through July 13, 2007, and (B) as to 40% of the total amount, seven years after 9/13/06. 10% of the total amount will vest on July 13, 2007.
- [F3]This stock option was approved on February 7, 2007 by the Equity Awards Subcommittee of the Compensation Committee of the Board of Directors, subject to shareholder approval of the amendment and restatement of the issuer's 2004 Incentive Compensation Plan, which the shareholders approved on June 14, 2007. The exercise price is equal to the closing market price of issuer's common stock on February 7, 2007.
- [F4]This stock option vests in equal monthly amounts over four years from February 7, 2007 in accordance with the issuer's 2004 Incentive Compensation Plan.
- [F5]This stock option was approved on May 31, 2007 by the Equity Awards Subcommittee of the Compensation Committee of the Board of Directors, subject to shareholder approval of the amendment and restatement of the issuer's 2004 Incentive Compensation Plan, which the shareholders approved on June 14, 2007. The exercise price is equal to the closing market price of issuer's common stock on May 31, 2007.
- [F6]This stock option vests in equal monthly amounts over four years from May 31, 2007 in accordance with the issuer's 2004 Incentive Compensation Plan.